Victory Capital Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,438,438
Closed -$15M 2519
2023
Q2
$15M Sell
1,438,438
-2,429,270
-63% -$23.4M 0.02% 885
2023
Q1
$40M Sell
3,867,708
-393,766
-9% -$5.04M 0.04% 516
2022
Q4
$58.7M Buy
4,261,474
+1,369,109
+47% +$19M 0.07% 387
2022
Q3
$59.2M Sell
2,892,365
-40,790
-1% -$895K 0.07% 397
2022
Q2
$56.8M Buy
2,933,155
+96,263
+3% +$1.97M 0.06% 422
2022
Q1
$61.1M Buy
2,836,892
+622,430
+28% +$14.1M 0.06% 442
2021
Q4
$61.1M Sell
2,214,462
-92,203
-4% -$2.54M 0.06% 481
2021
Q3
$59.8M Sell
2,306,665
-36,341
-2% -$972K 0.06% 465
2021
Q2
$63.6M Sell
2,343,006
-756,451
-24% -$18.5M 0.06% 456
2021
Q1
$72.5M Sell
3,099,457
-1,468,813
-32% -$29.7M 0.07% 389
2020
Q4
$70M Sell
4,568,270
-488,390
-10% -$6.2M 0.08% 388
2020
Q3
$61M Buy
5,056,660
+240,600
+5% +$2.28M 0.08% 385
2020
Q2
$49M Sell
4,816,060
-4,788,110
-50% -$49.3M 0.07% 428
2020
Q1
$100M Buy
9,604,170
+5,015,887
+109% +$63M 0.08% 335
2019
Q4
$73.5M Buy
4,588,283
+553,983
+14% +$8.46M 0.09% 324
2019
Q3
$74.3M Buy
4,034,300
+260,757
+7% +$5.1M 0.1% 299
2019
Q2
$74.3M Buy
3,773,543
+1,086,847
+40% +$22.1M 0.15% 191
2019
Q1
$61.4M Buy
2,686,696
+744,085
+38% +$16.2M 0.14% 207
2018
Q4
$39.1M Buy
1,942,611
+924,691
+91% +$19.1M 0.1% 316
2018
Q3
$22.1M Buy
+1,017,920
New +$22.6M 0.05% 577

Other funds holding ANGO

Victory Capital Management's ANGO Position: Q3 2023 in Review

Victory Capital Management sold out of AngioDynamics (ANGO) in Q3 2023, closing a stake of 1,438,438 shares — an estimated $15M sold.

Victory Capital Management first reported a position in ANGO in Q3 2018 and held it in 20 quarters. The position peaked at $100M in Q1 2020. 154 funds tracked by Wall St. Rank hold ANGO as of Q3 2023.

  • Victory Capital Management reported no remaining AngioDynamics position as of Q3 2023 after selling out during the quarter.
  • Victory Capital Management sold 1,438,438 AngioDynamics shares in Q3 2023, an estimated $15M.
  • Victory Capital Management first reported a position in AngioDynamics in Q3 2018 and held it in 20 quarters.
  • Victory Capital Management's AngioDynamics position peaked at $100M in Q1 2020.
  • 154 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2023.

Based on Victory Capital Management's 13F filing for Q3 2023, filed 6 Nov 2023.